SCHEMBL284983

SCHEMBL284983

NCCCCC(N)CC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.56
RNPEP Q9H4A4 1/20 0.48
CYP2D6 P10635 1/20 0.46
NFKB1 P19838 1/20 0.46
ENPEP Q07075 3/20 0.45
ALDH1A1 P00352 2/20 0.44
BLM P54132 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
LMNA P02545 2/20 0.44
THRB P10828 2/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
PLG P00747 1/20 0.44
ALOX15 P16050 1/20 0.44
SLC6A2 P23975 1/20 0.44
RECQL P46063 1/20 0.44
SLC6A3 Q01959 1/20 0.44
CPB2 Q96IY4 2/20 0.44
GABRR1 P24046 3/20 0.42
GABRR3 A8MPY1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL289144 1.00 GSR (0.56) GSRRNPEPCYP2D6NFKB1ENPEP
SCHEMBL30514395 1.00 GSR (0.56) GSRRNPEPCYP2D6NFKB1ENPEP
SCHEMBL288798 0.98 GSR (0.54) GSRRNPEPCYP2D6NFKB1ENPEP
SCHEMBL60354 0.93 GSR (0.46) GSRRNPEPCYP2D6NFKB1ENPEP
SCHEMBL159650 0.93 GSR (0.46) GSRRNPEPCYP2D6NFKB1ENPEP
SCHEMBL288689 0.93 GSR (0.46) GSRRNPEPCYP2D6NFKB1ENPEP
SCHEMBL562061 0.93 GSR (0.46) GSRRNPEPCYP2D6NFKB1ENPEP
Hydrochloric Acid SCHEMBL31510869 0.91 GSR (0.45) GSRRNPEPCYP2D6NFKB1ENPEP
Ammonia Solution, Strong SCHEMBL8677036 0.91 GSR (0.45) GSRRNPEPCYP2D6NFKB1ENPEP
Propionic Acid SCHEMBL29234998 0.85 S1PR2 (0.45) GSRCYP2D6NFKB1ENPEPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230022727-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID GENOMATICA INC (US) 2023-01-26 US claimed
US-20170114096-A1 ANTIBIOTIC PEPTIDES AMP-THERAPEUTICS GMBH (DE) 2017-04-27 US claimed
US-20150299256-A1 ANTIBIOTIC PEPTIDES AMP-THERAPEUTICS GMBH (DE) 2015-10-22 US claimed
US-20120021975-A1 ANTIBIOTIC PEPTIDES AMP-THERAPEUTICS GMBH & CO., KG 2012-01-26 US claimed
EP-1959729-B1 TRAPPING DEVICE FOR FRUGIVOROUS INSECTS ES DE DESARROLLOS QUIMICOS S L SOC (ES) 2011-05-18 EP claimed
EP-1959729-A1 TRAPPING DEVICE FOR FRUGIVOROUS INSECTS Sociedad Española de Desarrollos Quimicos S.L. (ES) 2008-08-27 EP claimed
WO-2007068329-A1 TRAPPING DEVICE FOR FRUGIVOROUS INSECTS SOCIEDAD ESPAÑOLA DE DESARROLLOS QUIMICOS S.L. (ES) 2007-06-21 WO claimed
EP-0435352-B1 A method of processing silver halide colour photographic photosensitive materials FUJI PHOTO FILM CO LTD (JP) 1998-03-25 EP claimed
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES AGAIN BIO APS (DK) 2026-01-29 US disclosed
US-12503711-B2 Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism GENOMATICA, INC. (US) 2025-12-23 US disclosed
US-20250170224-A1 METHODS AND COMPOSITIONS FOR TREATING MICROGLIAL DYSFUNCTION AND IMPROVING METABOLIC DYSFUNCTION ALBERT-LUDWIGS-UNIVERSITAT FREIBURG (DE) 2025-05-29 US disclosed
US-12240890-B2 Compositions and methods for treating and/or preventing pathogenic fungal infection and for maintenance of microbiome commensalism THE UNIVERSITY OF CHICAGO (US) 2025-03-04 US disclosed
US-12226444-B2 Compositions comprising peptides comprising variant kinesin light chain 1 and cell-penetrating peptides NORTHWESTERN UNIVERSITY (US) 2025-02-18 US disclosed
CN-114728871-B Microorganisms and methods for reducing byproducts 基因组股份公司 2024-12-27 CN disclosed
US-20100317069-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID AGAIN BIO APS (DK) 2010-12-16 US disclosed
WO-2010129936-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF ADIPATE, HEXAMETHYLENEDIAMINE AND 6-AMINOCAPROIC ACID GENOMATICA, INC. (US) 2010-11-11 WO disclosed
WO-2010123085-A1 TRAPPING COMPOUNDS AND METHOD FOR IDENTIFYING REACTIVE METABOLITES EISAI R & D MANAGEMENT CO., LTD. (JP) 2010-10-28 WO disclosed
US-4983328-A ANTITUMOR AGENTS BRISTOL-MYERS COMPANY (US) 1991-01-08 US disclosed
US-4518532-A ANTITIMOR ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) 1985-05-21 US disclosed
US-4430346-A N-(4-(3-AMINOPROPYL)AMINOBUTYL)-2-(CS)-7-GUANIDINO-3 -HYDROXYHEPTANAMIDE)-2-HYDROXYETHANAMIDE, ESTERS, AMIDATION ACID CATALYST BRISTOL-MYERS COMPANY (US) 1984-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028651-A1 METHOD OF PRODUCING & PROCESSING DIAMINES DDC, DAO, ODC1 GSR 2365/4885RNPEP 1159/4885CYP2D6 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.